thiazolyl blue has been researched along with Fungal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abruzzetti, A; Arzeni, D; Barchiesi, F; Castelletti, S; Cirioni, O; Ganzetti, G; Giacometti, A; Kamysz, E; Kamysz, W; Offidani, AM; Riva, A; Scalise, G; Silvestri, C; Simonetti, O; Spreghini, E | 1 |
| Donnelly, JP; Meis, JF; Meletiadis, J; Mouton, JW; Verweij, PE | 1 |
2 other study(ies) available for thiazolyl blue and Fungal Diseases
| Article | Year |
|---|---|
In vitro susceptibility of dermatophytes to conventional and alternative antifungal agents.
Topics: Antifungal Agents; Arthrodermataceae; Biomass; Cyclohexane Monoterpenes; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Microbial Viability; Microsporum; Monoterpenes; Mycoses; Tetrazolium Salts; Thiazoles; Trichophyton | 2009 |
Comparison of NCCLS and 3-(4,5-dimethyl-2-Thiazyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method.
Topics: Antifungal Agents; Formazans; Humans; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Oxidation-Reduction; Reproducibility of Results; Tetrazolium Salts; Thiazoles | 2000 |